In this context we decided to explore the clinical impact of ENDOG in CLL as a model of B-cell neoplasm in which the PI3K-AKT axis is constitutively activated and required for cell survival and proliferation [18]. This evidence concerns the gene ENDOG and B-cell chronic lymphocytic leukemia.